Identifying interactions in omics data for clinical biomarker discovery using symbolic regression
N. J. ChristenseniD, Samuel DemharteriD, Meera MachadoiD, Lykke PederseniD, Marco SalvatoreiD, Valdemar Stentoft-HanseniD, Miquel Triana Iglesias
Abstract
The identification of predictive biomarker signatures from omics data for clinical applications is an active area of research. Recent developments in assay technologies and machine learning (ML) methods have led to significant improvements in predictive performance. However, most high-performing ML methods suffer from complex architectures and lack interpretability. Here, we present the application of a novel symbolic-regression-based algorithm, the QLattice, on a selection of clinical omics data sets. This approach generates parsimonious high-performing models that can both predict disease outcomes and reveal putative disease mechanisms. Due to their high performance, simplicity and explicit functional form, these biomarker signatures can be readily explained, thereby making them attractive tools for high-stakes applications in primary care, clinical decision making and patient stratification.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 50
- FWCI
- 7.49
- Field percentile
- top 3%
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Transparent exploration of machine learning for biomarker discovery from proteomics and omics data
M. T. Strauss, F. M. Torun, … P. E. Geyer·Journal of Proteome ResearchPeer-reviewed·Nov 25, 2022
- AutoXAI4Omics: an Automated Explainable AI tool for Omics and tabular data
J. Strudwick, L.-J. Gardiner, … A. P. Carrieri·bioRxiv·Mar 25, 2024
- playOmics: A multi-omics pipeline for interpretable predictions and biomarker discovery
Jagoda Głowacka‐Walas, Kamil Sijko, … Tomasz Gambin·bioRxiv·Mar 12, 2024
- High-dimensional Biomarker Identification for Scalable and Interpretable Disease Prediction via Machine Learning Models
Yifan Dai, Di Wu, … Baiming Zou·BioinformaticsPeer-reviewed·Apr 25, 2025
- A supervised Bayesian factor model for the identification of multi-omics signatures
Jeremy P. Gygi, Anna Konstorum, … Leying Guan·BioinformaticsPeer-reviewed·Apr 10, 2024
- A flexible framework for minimal biomarker signature discovery from clinical omics studies without library size normalisation
Daniel Rawlinson, Chenxi Zhou, … RAPIDS Study Group·PLOS Digital HealthPeer-reviewed·Mar 26, 2025